phoneFree call from UK 0800 52 00 161 / Other countries: +34 960 451 185 personPrivate Area

Press room

Press room

21 November 2019
More than 20% of women between the ages of 30 and 34 have a low ovarian reserve

Of the more than 3,000 women who participated in the IVI study, 10% finally opted for reproductive treatment Today, women take on their thirties with vitality, multiple challenges in the different areas of their lives and full physical and mental capacity. Unfortunately, their biology does not follow the same path as far as fertility is… View Article

Laboratorio IVI Sevilla
14 November 2019
IVI Sevilla has enabled the birth of a baby who has succeeded in curing his sister’s rare disease

This is the first case in the world involving HLA-compatible pre-embryo biopsy at blastocyst stage to cure Diamond-Blackfan anaemia, and the first in Spain for any disease. Up to now, all cases had involved biopsy at day 3 of pre-embryo development and not after 5-6 days, when the chances of implantation and pregnancy are much… View Article

19 October 2019
Susana: “I held on to the wild card of preservation for a chance of motherhood in the future”

Susana, Irene and Estrella, three brave women who have won the battle against breast cancer. The desire to become mothers in the future gave them the strength to beat their illness. IVI launched its free “Becoming a Mother after Cancer” Programme in 2007. Since then, more than 800 women diagnosed with breast cancer have vitrified… View Article

16 October 2019
Women and couples with 3 normal embryos have a 95% chance of becoming pregnant

Genetic tests prior to implantation such as PGT-A allow abnormal embryos to be identified with precision without affecting implantation rates when biopsies are performed. The PGT-A test has enabled multiple pregnancies to be reduced and, as a result, has evened up birth weights between babies born through IVF and those conceived naturally. IVI presents an… View Article

1 October 2019
IVI reduces twin birth by 75% in the last decade

This type of pregnancies is associated with significant risks for both the mother and the newborn. According to the data published by SEF (Spanish Fertility Society), double embryo transfer numbers dropped from 82% in 2012 to 56% in 2016. The Belgian model in public health care shows a positive impact of the implemented policies, with… View Article

11 September 2019
Treatments with donated embryos triple in the last decade

Women who decide to face maternity alone with both donated gametes constitute 37% of all patients choosing embryo donation VALENCIA, 11 OF SEPTEMBER 2019 Embryo donation makes the dream of becoming parents true for women and couples who cannot become pregnant with their own gametes. In the last decade only, fertility treatments involving donated embryos… View Article

12 August 2019
A study by IVI Sevilla in collaboration with the IIQ (CSIC) yields new data on the possible causes of polycystic ovary syndrome

These findings allow a deeper understanding of the causes of polycystic ovary syndrome and could lead to the development of new treatments. This disease affects around 5-15% of women of reproductive age and is one of the most common causes of infertility. IVI Sevilla, together with the Instituto de Investigaciones Químicas (the Institute of Chemical… View Article

PRESS ROOM CONTACTS

  • Mar González
  • Javier Ybarra
  • Lucía Renau
  • Dori Argente
  • Email: [email protected]
  • Phone number: (0034) 96 317 36 10
  • Calle Colón, 1 - 46004 (Valencia)

PRESS PACK

Last update
September 2019

Download PDF

Back to toparrow_drop_up
© 2019 IVI.
All rights reserved
Legal Notice
Cookies Policy
MAIN MENU
OTHER GROUP COMPANIES
ABOUT IVI
PRESS ROOM
HEAD OFFICES
COUNTRY
España Italia Portugal France Deutschland РОССИЯ UK
SOCIAL NETWORKS
© 2019 IVI.
All rights reserved
HEAD OFFICES
SOCIAL NETWORKS